Kun Wang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- Circular RNAs in diseases
- Inflammasome and immune disorders
- Cell death mechanisms and regulation
Papers in
-
- MicroRNA in disease regulation 42
- Cancer-related molecular mechanisms research 9
-
- Circular RNAs in diseases 20
- RNA modifications and cancer 15
- Congenital heart defects research 10
- Mitochondrial Function and Pathology 6
- Co-authors
- Peifeng Li (42 shared papers)Jianjin Shi (1 shared paper)Qi Sun (1 shared paper)Jingjin Ding (1 shared paper)Feng Shao (1 shared paper)Hanzi Sun (1 shared paper)Dacheng Wang (1 shared paper)Wang Liu (1 shared paper)
- Journals
- Molecular Therapy — Nucleic Acids (5 papers)Cell Death Discovery (5 papers)Journal of Cellular and Molecular Medicine (4 papers)Cell Death and Differentiation (4 papers)Oncology Reports (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Kun Wang
142 papers receiving 9.9k citations
Kun Wang's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 2.4k
- Molecular Biology 5.6k
- Cardiology and Cardiovascular Medicine 997
- Pathology and Forensic Medicine 590
- Immunology 425
Countries citing papers authored by Kun Wang
This map shows the geographic impact of Kun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Wang more than expected).
Fields of papers citing papers by Kun Wang
This network shows the impact of papers produced by Kun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Wang. The network helps show where Kun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pore-forming activity and structural autoinhibition of the gasdermin family Hit paper breakdown → | 2016 | 2296 |
| 2 | A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223 Hit paper breakdown → | 2016 | 764 |
| 3 | 2010 | 529 | |
| 4 | The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489 Hit paper breakdown → | 2014 | 491 |
| 5 | 2017 | 294 | |
| 6 | 2017 | 285 | |
| 7 | 2018 | 221 | |
| 8 | 2019 | 180 | |
| 9 | 2008 | 174 | |
| 10 | 2012 | 170 | |
| 11 | 2020 | 168 | |
| 12 | 2019 | 166 | |
| 13 | 2015 | 159 | |
| 14 | 2019 | 150 | |
| 15 | 2017 | 141 | |
| 16 | 2010 | 139 | |
| 17 | 2017 | 116 | |
| 18 | 2019 | 108 | |
| 19 | 2018 | 102 | |
| 20 | 2013 | 101 |
About Kun Wang
Kun Wang is a scholar working on Cancer Research, Molecular Biology, Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 150 papers that have together received 10.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (42 papers), Circular RNAs in diseases (20 papers), RNA modifications and cancer (15 papers), Cardiac Fibrosis and Remodeling (13 papers), Congenital heart defects research (10 papers), Cancer-related molecular mechanisms research (9 papers), Cardiac Ischemia and Reperfusion (7 papers) and Mitochondrial Function and Pathology (6 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (5.6k citations), Cardiology and Cardiovascular Medicine (997 citations), Pathology and Forensic Medicine (590 citations) and Immunology (425 citations). Kun Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Peifeng Li, Jianjin Shi, Qi Sun, Jingjin Ding, Feng Shao, Hanzi Sun, Dacheng Wang, Wang Liu, Bo Long and Lu‐Yu Zhou. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Cell Death Discovery, Journal of Cellular and Molecular Medicine, Cell Death and Differentiation and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.